e8vk
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report: July 26, 2005
(Date of earliest event reported)
ORTHOLOGIC CORP.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-21214
|
|
86-0585310 |
|
|
|
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.) |
|
|
|
|
|
1275 West Washington Street, Tempe, Arizona
|
|
85281 |
|
|
|
(Address of principal executive offices
|
|
(Zip Code) |
Registrants telephone number, including area code:
(602) 286-5520
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
|
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Section 2 Financial Information
Item 2.02 Results of Operations and Financial Condition.
On July 26, 2005, OrthoLogic Corp. announced by press release its financial results for the
three months ended June 30, 2005. A copy of the press release is attached hereto as Exhibit 99.1
and incorporated by reference herein.
Section 9 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.
|
|
|
Exhibit No. |
|
Description |
99.1
|
|
Press release dated July 26, 2005 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
Dated: July 26, 2005 |
ORTHOLOGIC CORP.
|
|
|
/s/ Dr. James M. Pusey
|
|
|
Dr. James M. Pusey |
|
|
Chief Executive Officer |
|
|